ArticleBlood neoplasia2024

Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignancies.

Lawrence A Stern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.